Bunnik, Evelien M.

Broadly inhibitory antibodies against severe malaria virulence proteins

Reyes, R. A., Raghavan, S. S. R., Hurlburt, N. K., Introini, V., Kana, I. H., Jensen, R. W., Martinez-Scholze, E., Gestal-Mato, M., Bau, C. B., Fernández-Quintero, M. L., et al. (2024) · Nature

Malaria Research and ControlMonoclonal and Polyclonal Antibodies Research

Cited by 35

Broadly inhibitory antibodies to severe malaria virulence proteins

Reyes, R. A., Raghavan, S. S. R., Hurlburt, N. K., Introini, V., Bol, S., Kana, I. H., Jensen, R. W., Martinez-Scholze, E., Gestal-Mato, M., López-Gutiérrez, B., et al. (2024) · Nature

Malaria Research and ControlMonoclonal and Polyclonal Antibodies Research

Cited by 35

The N-terminal region of malaria vaccine candidate asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies

Garza, R., Marchioni, J. M., Honeycutt, J. D., Hurlburt, N. K., Torres, C., Garcia, A., Neog, S., Loranc, E., Yemington, E., Towers, D., et al. (2026) · Disease Models & Mechanisms

Malaria Research and Controlvaccines and immunoinformatics approaches

Cited by 1

The N-terminal region of malaria vaccine candidate Plasmodium falciparum asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies

Garza, R., Marchioni, J. M., Honeycutt, J. D., Hurlburt, N. K., Torres, C., Garcia, A., Loranc, E., Yemington, E., Towers, D., Ssewanyana, I., et al. (2025) · Disease Models & Mechanisms

Malaria Research and Controlvaccines and immunoinformatics approaches

Cited by 1